REPORTS

Let’s Pullulate and Expand Your Business

Glycobiology Market - Global Professional Analysis and Forecast to 2026

Mar 02, 2020  |  187 PAGES  |  REPORT CODE: CMM269746
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Glycobiology market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.

This report presents the market size and development trends by detailing the Glycobiology market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Glycobiology market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Glycobiology industry and will help you to build a panoramic view of the industrial development.

Glycobiology Market, By Type:

  • Reagents

  • Instruments

  • Kits

  • Enzymes

Glycobiology Market, By Application:

  • Drug Discovery and Development

  • Immunology

  • Diagnostics

  • Oncology

  • Others

Some of the leading players are as follows:

  • Agilent Technologies

  • Thermo Fisher Scientific

  • Waters Corp

  • Merck

  • Shimadzu Corp

  • Bruker Corp

  • Prozyme

  • New England Biolabs

  • Takara Bio

  • Danaher Corp

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Glycobiology Market: Technology Type Analysis

  • 4.1 Glycobiology Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Glycobiology Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Reagents

    • 4.3.2 Instruments

    • 4.3.3 Kits

    • 4.3.4 Enzymes

5 Glycobiology Market: Product Analysis

  • 5.1 Glycobiology Product Market Share Analysis, 2018 & 2026

  • 5.2 Glycobiology Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Glycobiology Market: Application Analysis

  • 6.1 Glycobiology Application Market Share Analysis, 2018 & 2026

  • 6.2 Glycobiology Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Drug Discovery and Development

    • 6.3.2 Immunology

    • 6.3.3 Diagnostics

    • 6.3.4 Oncology

    • 6.3.5 Others

7 Glycobiology Market: Regional Analysis

  • 7.1 Glycobiology Regional Market Share Analysis, 2018 & 2026

  • 7.2 Glycobiology Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Agilent Technologies

    • 9.1.1 Agilent Technologies Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Thermo Fisher Scientific

    • 9.2.1 Thermo Fisher Scientific Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Waters Corp

    • 9.3.1 Waters Corp Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Merck

    • 9.4.1 Merck Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Shimadzu Corp

    • 9.5.1 Shimadzu Corp Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Bruker Corp

    • 9.6.1 Bruker Corp Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Prozyme

    • 9.7.1 Prozyme Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 New England Biolabs

    • 9.8.1 New England Biolabs Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Takara Bio

    • 9.9.1 Takara Bio Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Danaher Corp

    • 9.10.1 Danaher Corp Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 87 Figures and 147 Tables)

  • Figure Reagents Glycobiology market, 2015 - 2026 (USD Million)

  • Figure Instruments Glycobiology market, 2015 - 2026 (USD Million)

  • Figure Kits Glycobiology market, 2015 - 2026 (USD Million)

  • Figure Enzymes Glycobiology market, 2015 - 2026 (USD Million)

  • Figure Drug Discovery and Development market, 2015 - 2026 (USD Million)

  • Figure Immunology market, 2015 - 2026 (USD Million)

  • Figure Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Glycobiology market, by country, 2015 - 2026 (USD Million)

  • Table North America Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table North America Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table North America Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Canada Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Canada Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Europe Glycobiology market, by country, 2015 - 2026 (USD Million)

  • Table Europe Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Europe Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Europe Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Germany Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Germany Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table France Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table France Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Italy Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Italy Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Spain Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Spain Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glycobiology market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table China Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table China Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Japan Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Japan Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table India Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table India Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Glycobiology market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table MEA Glycobiology market, by country, 2015 - 2026 (USD Million)

  • Table MEA Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table MEA Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table MEA Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Glycobiology market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Glycobiology market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Glycobiology market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Waters Corp Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shimadzu Corp Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bruker Corp Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Prozyme Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table New England Biolabs Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takara Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Danaher Corp Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top